1. Home
  2. DMAC vs NREF Comparison

DMAC vs NREF Comparison

Compare DMAC & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DMAC
  • NREF
  • Stock Information
  • Founded
  • DMAC 2000
  • NREF 2019
  • Country
  • DMAC United States
  • NREF United States
  • Employees
  • DMAC N/A
  • NREF N/A
  • Industry
  • DMAC Biotechnology: Pharmaceutical Preparations
  • NREF Real Estate Investment Trusts
  • Sector
  • DMAC Health Care
  • NREF Real Estate
  • Exchange
  • DMAC Nasdaq
  • NREF Nasdaq
  • Market Cap
  • DMAC 274.1M
  • NREF 310.3M
  • IPO Year
  • DMAC N/A
  • NREF 2020
  • Fundamental
  • Price
  • DMAC $4.82
  • NREF $15.90
  • Analyst Decision
  • DMAC Strong Buy
  • NREF Hold
  • Analyst Count
  • DMAC 3
  • NREF 3
  • Target Price
  • DMAC $7.00
  • NREF $13.75
  • AVG Volume (30 Days)
  • DMAC 118.6K
  • NREF 46.6K
  • Earning Date
  • DMAC 11-13-2024
  • NREF 10-31-2024
  • Dividend Yield
  • DMAC N/A
  • NREF 12.58%
  • EPS Growth
  • DMAC N/A
  • NREF N/A
  • EPS
  • DMAC N/A
  • NREF 1.32
  • Revenue
  • DMAC N/A
  • NREF $73,164,000.00
  • Revenue This Year
  • DMAC N/A
  • NREF N/A
  • Revenue Next Year
  • DMAC N/A
  • NREF $34.61
  • P/E Ratio
  • DMAC N/A
  • NREF $12.02
  • Revenue Growth
  • DMAC N/A
  • NREF 224.04
  • 52 Week Low
  • DMAC $2.14
  • NREF $12.63
  • 52 Week High
  • DMAC $6.41
  • NREF $18.09
  • Technical
  • Relative Strength Index (RSI)
  • DMAC 47.28
  • NREF 35.90
  • Support Level
  • DMAC $5.05
  • NREF $17.00
  • Resistance Level
  • DMAC $5.74
  • NREF $18.09
  • Average True Range (ATR)
  • DMAC 0.37
  • NREF 0.54
  • MACD
  • DMAC -0.08
  • NREF -0.25
  • Stochastic Oscillator
  • DMAC 28.10
  • NREF 14.78

About DMAC DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. It provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

Share on Social Networks: